Scientist, Quantitative Biology (Job Code #SCIQB)

FLX Bio is a biotechnology company focused on the discovery and development of novel drugs that will improve and prolong the lives of people with cancer. The company is led by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is supported by several of the nation’s premier life sciences venture capital firms. The company is located in the San Francisco Bay area, in the heart of the world’s largest biotechnology research hub. We offer a competitive compensation and benefits package, including aggressive participation in the growth of the company in the form of stock option grants.

As a member of the Quantitative Biology group, the Scientist will join a dynamic and highly motivated team driving the discovery, characterization and development of immuno-modulatory drugs. The job calls for an understanding of small molecule drug discovery from hit identification through clinical candidate selection. As a key member of the group, the successful applicant will contribute to the development, optimization and execution of new biochemical and cell-based assays to support our internal drug discovery programs. This position requires working with others within Biology as well as with Medicinal Chemistry, Toxicology and DMPK. The Scientist is expected to contribute at the bench as well as at strategic levels. A strong candidate will be enthusiastic about supporting the operation of a dynamic laboratory, have great attention to detail and superior organizational skills.

The ideal candidate will have the following qualifications:

  • A Ph.D. in a relevant biological science with a minimum of two years of industry experience.
  • A strong record of publications in a relevant scientific discipline.
  • History of biochemical and/or cell-based assay development, optimization and troubleshooting in an automated laboratory environment.
  • Deep knowledge of structural biology, protein biochemistry and/or enzymology.
  • Strong desire to develop novel therapies that will improve and prolong the lives of people with cancer.
  • Be eligible to work in the United States.

The role demands a highly goal-driven approach and the ability to focus on time-sensitive objectives. The candidate should also enjoy operating in an exceptionally dynamic and cooperative environment where every voice matters.

A strong working knowledge of immunology, oncology, or other human disease field is desirable.  Particular consideration will be given to candidates with experience in a pharmaceutical or biopharmaceutical drug discovery environment. 

 

Located in South San Francisco, Calif., and funded by leading investors, including The Column Group (TCG), Kleiner Perkins (KP), Topspin Partners, GV (formerly Google Ventures) and Celgene Corporation, FLX Bio has assembled a leadership team and advisory group with a proven track record of success and team of scientists with substantial knowledge and expertise in drug discovery and translational areas essential to execute on this approach. For more information, please visit www.flxbio.com.

 

Qualified candidates are encouraged to submit a Resume/CV and cover letter to careers@flxbio.com and please refer to job code #SCIQB.  We are proud to be an equal opportunity employer.